Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational MRNA Norovirus Vaccine, MRNA-1403

Accesswire09/30 19:00

Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed

Yahoo Finance09/29 09:45

Moderna Enters Green After Six Straight Sessions in Red

Seeking Alpha09/27 04:05

Moderna Blamed After Children Offered £1,500 to Take Part in Covid-19 Trial

Yahoo Finance09/26 22:53

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry

PR Newswire09/26 18:00

Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade

Yahoo Finance09/25 05:50